Coprosterol

Coprosterol is a lipid of Sterol Lipids (ST) class. Coprosterol is associated with abnormalities such as Cerebrovascular accident, Glycogen Storage Disease Type IV, Coronary Arteriosclerosis, CARDIAC EVENT and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as cholesterol absorption, Death, Sudden, Cardiac, Drug Interactions, Cholesterol Homeostasis and Synthesis. Coprosterol often locates in lipid raft, Tissue membrane, Membrane, Blood and Body tissue. The associated genes with Coprosterol are ABO gene, STN gene, Alleles, Apolipoprotein E gene and TNF gene. The related lipids are saturated fat, campesterol, lathosterol, Sterols and Total cholesterol. The related experimental models are Rodent Model.

Cross Reference

Introduction

To understand associated biological information of Coprosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Coprosterol?

Coprosterol is suspected in Coronary Arteriosclerosis, Cerebrovascular accident, Glycogen Storage Disease Type IV, CARDIAC EVENT, Diabetes Mellitus, Non-Insulin-Dependent, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Coprosterol

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Cataract D002386 34 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alcoholism D000437 27 associated lipids
Brain Diseases, Metabolic D001928 9 associated lipids
Biliary Fistula D001658 13 associated lipids
Xanthomatosis D014973 17 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 9

PubChem Associated disorders and diseases

What pathways are associated with Coprosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Coprosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Coprosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Coprosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Coprosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Coprosterol?

Rodent Model

Rodent Model are used in the study 'Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.' (Keller RK et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Coprosterol

Download all related citations
Per page 10 20 50 100 | Total 485
Authors Title Published Journal PubMed Link
Ratajczak MK et al. Cholesterol displacement from membrane phospholipids by hexadecanol. 2007 Biophys. J. pmid:17526582
Márk L and Paragh G [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption]. 2007 Orv Hetil pmid:17403635
Burghaus L et al. [Cerebrotendinous xanthomatosis]. 2007 Dtsch. Med. Wochenschr. pmid:17583829
Sittiwet C et al. Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: the effect of improved glycemic control. 2007 Atherosclerosis pmid:16996519
Miettinen TA and Gylling H Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. 2007 Clin. Chim. Acta pmid:17258182
Blokland MH et al. Development of a method which discriminates between endogenous and exogenous beta-boldenone. 2007 Anal. Chim. Acta pmid:17386706
Szalat A et al. Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment. 2007 Biochim. Biophys. Acta pmid:17553741
Shah VG et al. Comparisons of water quality parameters from diverse catchments during dry periods and following rain events. 2007 Water Res. pmid:17428519
Clark DT and Soory M Steroid 5alpha-reductase activity of Treponema denticola. 2007 Oral Microbiol. Immunol. pmid:17803630
Panzenboeck U et al. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. 2007 J. Lipid Res. pmid:17325385
Hong YJ et al. Simultaneous characterization of bile acid, sterols, and determination of acylglycerides in feces from soluble cellulose-fed hamsters using HPLC with evaporative light-scattering detection and APCI-MS. 2007 J. Agric. Food Chem. pmid:17979236
Stefens JL et al. Lipid biomarkers profile--presence of coprostanol: recent sediments from Rodrigo de Freitas Lagoon-Rio de Janeiro, Brazil. 2007 J Environ Sci Health A Tox Hazard Subst Environ Eng pmid:17849296
Poerschmann J et al. Investigation of the solvent extracts of humic organic matter (HOM) isolated from the Ravenna Lagoon to study environmental pollution and microbial communities. 2007 Chemosphere pmid:17663998
Shah VG et al. Evaluating potential applications of faecal sterols in distinguishing sources of faecal contamination from mixed faecal samples. 2007 Water Res. pmid:17614115
Tyagi P et al. Use of selected chemical markers in combination with a multiple regression model to assess the contribution of domesticated animal sources of fecal pollution in the environment. 2007 Chemosphere pmid:17590407
Shah VG et al. Bacterial source tracking from diverse land use catchments by sterol ratios. 2007 Water Res. pmid:17433407
Bouhnik Y et al. Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. 2007 Nutr J pmid:18053236
Marounek M et al. Effect of pectin and amidated pectin on cholesterol homeostasis and cecal metabolism in rats fed a high-cholesterol diet. 2007 Physiol Res pmid:16925468
Li D et al. Application of nonylphenol and coprostanol to identification of industrial and fecal pollution in Korea. 2007 Mar. Pollut. Bull. pmid:17097116
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Lancelot E and Grauby-Heywang C Comparison of the interaction of dihydrocholesterol and cholesterol with sphingolipid or phospholipid Langmuir monolayers. 2007 Colloids Surf B Biointerfaces pmid:17544260
Bhattacharyya AK et al. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition. 2007 J. Lipid Res. pmid:17012751
Nagy K et al. Analysis of sterols by high-performance liquid chromatography/mass spectrometry combined with chemometrics. 2006 Rapid Commun. Mass Spectrom. pmid:16841361
Stine KJ et al. Interaction of the glycoalkaloid tomatine with DMPC and sterol monolayers studied by surface pressure measurements and Brewster angle microscopy. 2006 J Phys Chem B pmid:17078662
Hashimoto N et al. Potato pulps lowered the serum cholesterol and triglyceride levels in rats. 2006 J. Nutr. Sci. Vitaminol. pmid:17330508
Järvisalo M et al. Cholesterol absorption and synthesis in children with type 1 diabetes. 2006 Diabetes Care pmid:17003310
Hu Y et al. Thermodynamic equilibrium of domains in a two-component Langmuir monolayer. 2006 Biophys. J. pmid:16632506
Agren JJ et al. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency. 2006 Clin. Chim. Acta pmid:16364276
Hallikainen M et al. Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption. 2006 Clin. Chim. Acta pmid:16814761
Li Z et al. First synthesis of free cholesterol-BODIPY conjugates. 2006 J. Org. Chem. pmid:16468832
Siman-Tov T et al. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis? 2006 J. Neurol. Sci. pmid:16445943
Hedman M et al. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. 2006 J. Pediatr. pmid:16492436
Loughrin JH and Szogi AA Free Fatty acids and sterols in swine manure. 2006 J Environ Sci Health B pmid:16393893
Berthold HK et al. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial. 2006 Drug Saf pmid:16872244
Hoenig MR et al. Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy. 2006 Atherosclerosis pmid:16216250
Gilli G et al. Faecal sterols determination in wastewater and surface water. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16787764
Gagné F et al. Effects of selected pharmaceutical products on phagocytic activity in Elliptio complanata mussels. 2006 Comp. Biochem. Physiol. C Toxicol. Pharmacol. pmid:16533621
Gagné F et al. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. 2006 Ecotoxicol. Environ. Saf. pmid:15923035
Palmié-Peixoto IV et al. Effects of sterol biosynthesis inhibitors on endosymbiont-bearing trypanosomatids. 2006 FEMS Microbiol. Lett. pmid:16436059
Shah VK et al. An efficient diethyl ether-based soxhlet protocol to quantify faecal sterols from catchment waters. 2006 J Chromatogr A pmid:16430911
Tészás A et al. Presenile cataract: consider cholestanol. 2006 Arch. Ophthalmol. pmid:17030721
Gagné F et al. Effects of pharmaceutical products and municipal wastewaters on temperature-dependent mitochondrial electron transport activity in Elliptio complanata mussels. 2006 Comp. Biochem. Physiol. C Toxicol. Pharmacol. pmid:16777490
Stottrup BL and Keller SL Phase behavior of lipid monolayers containing DPPC and cholesterol analogs. 2006 Biophys. J. pmid:16461392
Beck M and Radke M Determination of sterols, estrogens and inorganic ions in waste water and size-segregated aerosol particles emitted from waste water treatment. 2006 Chemosphere pmid:16406486
Apel-Paz M et al. Impact of membrane cholesterol content on the resistance of vesicles to surfactant attack. 2005 Langmuir pmid:16229500
Nikkilä K et al. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation. 2005 Transpl. Int. pmid:15691276
Miettinen TA et al. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. 2005 J. Am. Coll. Cardiol. pmid:15936608
Rugonyi S et al. Kinetics for the collapse of trilayer liquid-crystalline disks from a monolayer at an air-water interface. 2005 Langmuir pmid:16042458
Peng X et al. Tracing anthropogenic contamination in the Pearl River estuarine and marine environment of South China Sea using sterols and other organic molecular markers. 2005 Mar. Pollut. Bull. pmid:16115503
Veiga P et al. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut. 2005 FEMS Microbiol. Lett. pmid:15621423